Rethinking How Life Sciences Organizations Approach AI – Mathias Cousin of Deloitte
This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines.…

•


Latest Coverage of AI in Life Sciences
This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines.…

•

Clinical trials comprise the most significant portion of drug development costs. In some cases, drug R&D costs can approach as high…

•

Generative AI has been accelerating transformation across the life sciences, leaving pharmaceutical companies and clinical research organizations facing a dual challenge:…

•

This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines.…

•

This interview analysis is sponsored by Pure Storage and was written, edited, and published in alignment with our Emerj sponsored content…

•

In healthcare, patient data is the foundation of diagnosis, treatment, and trust. With digital health systems and AI tools becoming central…

•

This interview analysis is sponsored by Clarivate and was written, edited, and published in alignment with our Emerj sponsored content guidelines.…

•
